129 related articles for article (PubMed ID: 15912969)
1. Fontolizumab Protein Design Labs.
Dumont FJ
Curr Opin Investig Drugs; 2005 May; 6(5):537-44. PubMed ID: 15912969
[TBL] [Abstract][Full Text] [Related]
2. Nuvion. Protein Design Labs.
Trajkovic V
Curr Opin Investig Drugs; 2002 Mar; 3(3):411-4. PubMed ID: 12054088
[TBL] [Abstract][Full Text] [Related]
3. Technology evaluation: epratuzumab, Immunomedics/Amgen.
Juweid M
Curr Opin Mol Ther; 2003 Apr; 5(2):192-8. PubMed ID: 12772511
[TBL] [Abstract][Full Text] [Related]
4. Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease.
Hommes DW; Mikhajlova TL; Stoinov S; Stimac D; Vucelic B; Lonovics J; Zákuciová M; D'Haens G; Van Assche G; Ba S; Lee S; Pearce T
Gut; 2006 Aug; 55(8):1131-7. PubMed ID: 16507585
[TBL] [Abstract][Full Text] [Related]
5. Bertilimumab Cambridge Antibody Technology Group.
Ding C; Li J; Zhang X
Curr Opin Investig Drugs; 2004 Nov; 5(11):1213-8. PubMed ID: 15573873
[TBL] [Abstract][Full Text] [Related]
6. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease.
Reinisch W; Hommes DW; Van Assche G; Colombel JF; Gendre JP; Oldenburg B; Teml A; Geboes K; Ding H; Zhang L; Tang M; Cheng M; van Deventer SJ; Rutgeerts P; Pearce T
Gut; 2006 Aug; 55(8):1138-44. PubMed ID: 16492717
[TBL] [Abstract][Full Text] [Related]
7. Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection.
John JF
Curr Opin Mol Ther; 2006 Oct; 8(5):455-60. PubMed ID: 17078388
[TBL] [Abstract][Full Text] [Related]
8. TRX-4 (TolerRx Inc).
Brown WM
IDrugs; 2006 Apr; 9(4):283-91. PubMed ID: 16596483
[TBL] [Abstract][Full Text] [Related]
9. ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases.
Ding C; Xu J; Li J
Curr Opin Investig Drugs; 2008 May; 9(5):515-22. PubMed ID: 18465662
[TBL] [Abstract][Full Text] [Related]
10. IDEC-114 (IDEC).
Schopf RE
Curr Opin Investig Drugs; 2001 May; 2(5):635-8. PubMed ID: 11569938
[TBL] [Abstract][Full Text] [Related]
11. Ibalizumab, a CD4-specific mAb to inhibit HIV-1 infection.
Dimitrov A
Curr Opin Investig Drugs; 2007 Aug; 8(8):653-61. PubMed ID: 17668367
[TBL] [Abstract][Full Text] [Related]
12. Drug discovery. Magnificent obsession.
Couzin J
Science; 2005 Mar; 307(5716):1712-5. PubMed ID: 15774740
[No Abstract] [Full Text] [Related]
13. Drug evaluation: CNTO-1275, a mAb against IL-12/IL-23p40 for the potential treatment of inflammatory diseases.
Wittig BM
Curr Opin Investig Drugs; 2007 Nov; 8(11):947-54. PubMed ID: 17979029
[TBL] [Abstract][Full Text] [Related]
14. Anti-gamma interferon (IFN-gamma) monoclonal antibodies.
Bach JF
Immunol Ser; 1993; 59():319-28. PubMed ID: 8461396
[No Abstract] [Full Text] [Related]
15. Technology evaluation: EMD-273063, EMD Lexigen.
Niculescu-Duvaz I
Curr Opin Mol Ther; 2004 Oct; 6(5):559-66. PubMed ID: 15537058
[TBL] [Abstract][Full Text] [Related]
16. Technology evaluation: mepolizumab, GlaxoSmithKline.
Gnanakumaran G; Babu KS
Curr Opin Mol Ther; 2003 Jun; 5(3):321-5. PubMed ID: 12870444
[TBL] [Abstract][Full Text] [Related]
17. MedImmune initiates phase I/II clinical study with Vitaxin.
Expert Rev Anticancer Ther; 2001 Aug; 1(2):166. PubMed ID: 12113018
[No Abstract] [Full Text] [Related]
18. Trends in the development of therapeutic anti-cytokine antibodies.
Reichert JM
Drug Discov Today; 2004 Apr; 9(8):348. PubMed ID: 15081960
[No Abstract] [Full Text] [Related]
19. Drug evaluation: TG-1042, an adenovirus-mediated IFNgamma gene delivery for the intratumoral therapy of primary cutaneous lymphomas.
Urosevic M
Curr Opin Investig Drugs; 2007 Jun; 8(6):493-8. PubMed ID: 17621880
[TBL] [Abstract][Full Text] [Related]
20. Mouse opens door for study of autoimmune diseases.
Check E
Nature; 2004 Apr; 428(6985):786. PubMed ID: 15103338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
